Literature DB >> 21595500

Recent advances in herbal medicine for treatment of liver diseases.

Nilanjan Ghosh1, Rituparna Ghosh, Vivekananda Mandal, Subhash C Mandal.   

Abstract

CONTEXT: Liver disease is a serious ailment and the scenario is worsened by the lack of precise therapeutic regimens. Currently available therapies for liver ailments are not apposite and systemic toxicity inhibits their long term use. Medicinal plants have been traditionally used for treating liver diseases since centuries as the toxicity factor appears to be on the lower side.
OBJECTIVE: Several phytochemials have been identified which have significant hepatoprotective activity with minimal systemic adverse effects which could limit their long term use. The scenario calls for extensive investigations which can lead to development of lead molecules for hepatoprotective molecules of future. This review deals with the biological activity, mode of action and toxicity and forthcoming application of some of these leads.
METHODS: These generally have strong antioxidative potential and cause induction of antioxidant enzymes like superoxide dismutase, reduced glutathione and catalase. Additional mechanisms of hepatoprotection include stimulation of heme oxygenase-1 activity, inhibition of nitric oxide production, hepatocyte apoptosis and nuclear factor-κB activation. RESULTS AND
CONCLUSION: Out of the several leads obtained from plant sources as potential hepatoprotective agents, silymarin, andrographolide, neoandrographolide, curcumin, picroside, kutkoside, phyllanthin, hypophyllanthin, and glycyrrhizin have been established as potent hepatoprotective agents. The hepatoprotective potential of several herbal medicines has been clinically evaluated. Significant efficacy has been seen with silymarin, glycyrrhizin and Liv-52 in treatment of hepatitis, alcoholic liver disease and liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21595500     DOI: 10.3109/13880209.2011.558515

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  23 in total

1.  Protective effect of andrographolide against concanavalin A-induced liver injury.

Authors:  Guojun Shi; Zhijian Zhang; Rong Zhang; Xiaofang Zhang; Yan Lu; Jian Yang; Di Zhang; Zhiguo Zhang; Xiaoying Li; Guang Ning
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-24       Impact factor: 3.000

2.  In vitro and in vivo antimutagenic effects of DIG, a herbal preparation of Berberis vulgaris, Taraxacum officinale and Arctium lappa, against mitomycin C.

Authors:  C Di Giorgio; L Boyer; M De Meo; C Laurant; R Elias; E Ollivier
Journal:  J Nat Med       Date:  2015-02-10       Impact factor: 2.343

3.  Chunggan extract, a traditional herbal formula, ameliorated alcohol-induced hepatic injury in rat model.

Authors:  Hyeong-Geug Kim; Jung-Min Kim; Jong-Min Han; Jin-Seok Lee; Min-Kyung Choi; Dong-Soo Lee; Yeon-Hwa Park; Chang-Gue Son
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

4.  Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study.

Authors:  Junhui Su; Cui Chang; Qi Xiang; Zhi-Wei Zhou; Rong Luo; Lun Yang; Zhi-Xu He; Hongtu Yang; Jianan Li; Yu Bei; Jinmei Xu; Minjing Zhang; Qihao Zhang; Zhijian Su; Yadong Huang; Jiyan Pang; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2014-12-12       Impact factor: 4.162

5.  Curcumin protects against concanavalin A-induced hepatitis in mice through inhibiting the cytoplasmic translocation and expression of high mobility group box 1.

Authors:  Chuan-tao Tu; Qun-yan Yao; Bei-li Xu; Shun-cai Zhang
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

6.  Blockade of high mobility group box 1 augments antitumor T-cell response induced by peptide vaccination as a co-adjuvant.

Authors:  Kayoko Waki; Akira Yamada
Journal:  Cancer Sci       Date:  2016-12-18       Impact factor: 6.716

7.  Comparison between the efficacies of curcumin and puerarin in C57BL/6 mice with steatohepatitis induced by a methionine- and choline-deficient diet.

Authors:  Yunliang Wang; Jian Li; Li Zhuge; Dongmei Su; Meijuan Yang; Shiying Tao; Junxiang Li
Journal:  Exp Ther Med       Date:  2013-12-24       Impact factor: 2.447

8.  GC-MS Analysis: In Vivo Hepatoprotective and Antioxidant Activities of the Essential Oil of Achillea biebersteinii Afan. Growing in Saudi Arabia.

Authors:  Mansour S Al-Said; Ramzi A Mothana; Mohammed M Al-Yahya; Syed Rafatullah; Mohammed O Al-Sohaibani; Jamal M Khaled; Abdulrahman Alatar; Naiyf S Alharbi; Mine Kurkcuoglu; Husnu C Baser
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-12       Impact factor: 2.629

9.  Untargeted Metabolomics Reveals Dose-Response Characteristics for Effect of Rhubarb in a Rat Model of Cholestasis.

Authors:  Cong-En Zhang; Ming Niu; Rui-Yu Li; Wu-Wen Feng; Xiao Ma; Qin Dong; Zhi-Jie Ma; Guang-Quan Li; Ya-Kun Meng; Ya Wang; Ping Yin; Lan-Zhi He; Yu-Meng Li; Peng Tan; Yan-Ling Zhao; Jia-Bo Wang; Xiao-Ping Dong; Xiao-He Xiao
Journal:  Front Pharmacol       Date:  2016-03-31       Impact factor: 5.810

10.  Intervening TNF-α via PPARγ with Gegenqinlian Decoction in Experimental Nonalcoholic Fatty Liver Disease.

Authors:  Yun-Liang Wang; Li-Juan Liu; Wei-Han Zhao; Jun-Xiang Li
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.